I-Linagliptin CAS: 668270-12-0 Umthengisi woMvelisi Umfanekiso oPhambili

Umthengisi weLinagliptin CAS: 668270-12-0

I-Linagliptin (amagama orhwebo i-Tradjenta kunye ne-Trajetna) sisithinteli se-dipeptidyl peptidase-4 (DPP-4) esavunywa yi-US FDA ngoMeyi 2011 kunyango lwesifo seswekile sohlobo lwesibini kunye nokutya kunye nokuzilolonga. I-Linagliptin (BI-1356) ichazwe njengesixhobo esinamandla esikhetha kakhulu, esicothayo kunye nesithinteli esisebenza ixesha elide se-DPP-4. I-Linagliptin yavela kwimizamo yokuphucula i-xanthine-based DPP-4 inhibitors kunye ne-lead yokuqala echongiweyo kwiphulo le-HTS.

Oda okanye Cela iKoteshini

Iinkcukacha zeMveliso

Iithegi zeMveliso

Ukusetyenziswa kunye nesiphumo

I-Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) sisithinteli se-dipeptidyl peptidase-4 esithathwa ngomlomo nesikhethwa kakhulu kwaye sisithako sokuqala sodidi lwayo esisuswa kakhulu ngendlela engeyiyo ye-renal. I-Linagliptin iboniswa ukuba isetyenziswe kanye ngemini kunyango lwabantu abadala abanesifo seswekile sohlobo lwesibini. I-Linagliptin isebenza ekunciphiseni amanqanaba eglucose egazini ngokuthintela i-enzyme DPP-4, ngaloo ndlela ithintela ukuwohloka kwee-hormone ze-incretin (i-glucagon-like peptide-1 [GLP-1] kunye ne-glucose-dependent insulinotropic peptide) kunye nokunciphisa ukuhamba kweglucose emva kokutya.

Isampuli yeMveliso

Ukupakisha imveliso:

Iinkcukacha ezongezelelweyo:

Ukwakhiwa	C25H28N8O2
Uvavanyo	99%
Inkangeleko	Umgubo omhlophe
Inombolo ye-CAS	668270-12-0
Ukupakisha	25KG
Beka ubomi kwishelufa	iminyaka eyi-2
Indawo yokugcina izinto	Gcina kwindawo epholileyo neyomileyo
Isiqinisekiso	I-ISO.